Moleculin Biotech is trading at $0.37 (-5.13%) as its recent $9.3 million public offering continues to weigh on shares.
- Completed on August 3, 2026, the offering comprised 12,376,667 shares and warrants for up to 37,130,001 shares.
- Securities were priced at $0.75 with immediately exercisable warrants, creating continued dilution and supply overhang.
- XBI gained 2.09%, but biotech strength is not offsetting company-specific financing pressure.